BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10463378)

  • 1. Treatment of alcohol withdrawal syndrome with gabapentin.
    Bonnet U; Banger M; Leweke FM; Maschke M; Kowalski T; Gastpar M
    Pharmacopsychiatry; 1999 May; 32(3):107-9. PubMed ID: 10463378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
    Myrick H; Malcolm R; Randall PK; Boyle E; Anton RF; Becker HC; Randall CL
    Alcohol Clin Exp Res; 2009 Sep; 33(9):1582-8. PubMed ID: 19485969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol.
    Bonnet U; Hamzavi-Abedi R; Specka M; Wiltfang J; Lieb B; Scherbaum N
    Alcohol Alcohol; 2010; 45(2):143-5. PubMed ID: 20019070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
    Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
    JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial.
    Bonnet U; Banger M; Leweke FM; Specka M; Müller BW; Hashemi T; Nyhuis PW; Kutscher S; Burtscheidt W; Gastpar M
    J Clin Psychopharmacol; 2003 Oct; 23(5):514-9. PubMed ID: 14520131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for the treatment of ethanol withdrawal.
    Voris J; Smith NL; Rao SM; Thorne DL; Flowers QJ
    Subst Abus; 2003 Jun; 24(2):129-32. PubMed ID: 12766380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.
    Mariani JJ; Rosenthal RN; Tross S; Singh P; Anand OP
    Am J Addict; 2006; 15(1):76-84. PubMed ID: 16449096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2012 Jul; 13(5):318-78. PubMed ID: 22834451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome.
    Amato L; Minozzi S; Davoli M
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD008537. PubMed ID: 21678378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.
    Stock CJ; Carpenter L; Ying J; Greene T
    Ann Pharmacother; 2013; 47(7-8):961-9. PubMed ID: 23780805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gabapentin in the management of alcohol withdrawal and dependence.
    Leung JG; Hall-Flavin D; Nelson S; Schmidt KA; Schak KM
    Ann Pharmacother; 2015 Aug; 49(8):897-906. PubMed ID: 25969570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anticonvulsants in the treatment of alcoholism.
    Book SW; Myrick H
    Expert Opin Investig Drugs; 2005 Apr; 14(4):371-6. PubMed ID: 15882114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin treatment of alcohol withdrawal.
    Myrick H; Malcolm R; Brady KT
    Am J Psychiatry; 1998 Nov; 155(11):1632. PubMed ID: 9812141
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
    Myrick H; Anton R; Voronin K; Wang W; Henderson S
    Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.
    Fischler PV; Soyka M; Seifritz E; Mutschler J
    Front Pharmacol; 2022; 13():927703. PubMed ID: 36263121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Peripheral Action of PICK1 Inhibition in Inflammatory Pain.
    Jensen KL; Noes-Holt G; Sørensen AT; Madsen KL
    Front Cell Neurosci; 2021; 15():750902. PubMed ID: 34975407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital.
    Vadiei N; Smith TL; Walton AE; Kjome KL
    Psychopharmacol Bull; 2019 Feb; 49(1):17-27. PubMed ID: 30858636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating gabapentin as a drug of abuse: A survey study of Kentucky community pharmacists.
    Blackmer J; Lindahl E; Strahl A; Schadler A; Freeman PR
    J Am Pharm Assoc (2003); 2019; 59(3):379-382. PubMed ID: 30786971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol.
    Meyerhoff DJ; Murray DE; Durazzo TC; Pennington DL
    Front Psychiatry; 2018; 9():78. PubMed ID: 29599727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.